CClinicalTrials.gg
CompletedNCT01148199Updated Jun 26, 2018

Self-expandable Metallic Stent Versus Multiple Plastic Stents in Post Orthotopic Liver Transplantation Biliary Stenosis

A Phase 2/3 interventional study of Self-expandable metalic stent and Multiple plastic stents in Biliary Anastomotic Stenosis and Biliary Stricture, sponsored by Hospital Israelita Albert Einstein. Completed at 1 site in Brazil. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-06-26.

Sponsored by Hospital Israelita Albert Einstein · Phase 2/3, Interventional, and Treatment

Phase
Phase 2/3
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Biliary complications are one of the most common problems after orthotopic liver transplantation (OLT),occurring in up to 24% of patients.

Anastomotic strictures have been endoscopically managed with plastic stents placement. Recently, partially and fully covered metal stents have been alternatively used to treat refractory benign biliary stenosis. The investigators purpose is to compare efficacy and safety of metallic stents versus multiple plastic stents in the endoscopic management of post transplant biliary complications.

Read the detailed description

Patients with biliary stricture after OLT will be randomly assigned following simple randomization to temporary placement of fully covered self-expandable metal stent (SEMS) or multiple plastic stents placement were randomized according to a computer generated randomization sequence and allocated in a 1:1 ratio to one of two treatment groups.

Final success will be defined as clinical resolution of the stricture without the need to repeat endoscopic, percutaneous or surgical treatment.

02

Conditions studied

  • Biliary Anastomotic Stenosis
  • Biliary Stricture

Keywords

  • biliary anastomotic stricture
  • orthotopic liver transplantation
  • ERCP
03

In context

Constriction, Pathologic

1,117 studies on the registry are indexed under Constriction, Pathologic; 231 are open to participants now.

This study's enrollment of 64 is below the median of 80 across 672 interventional studies indexed under Constriction, Pathologic.

Browse Constriction, Pathologic studies →

Lead sponsor

Hospital Israelita Albert Einstein is the lead sponsor of 143 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • post-OLT biliary anastomotic stenosis (at least 1 month post-operative)
  • jaundice, cholestasis and/or biliary tree dilation on US

Exclusion criteria

Exclusion Criteria:

  • biliary fistulae
  • non-anastomotic stricture
  • combine anastomotic and non-anastomotic stricture
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (actual)

Study arms

  • Active comparator
    Multiple plastic stents

    Multiple plastic stents placement after sphincterotomy and stricutre dilation. ERCP repeated every 3 - 4 months during 1-year

    Device: Multiple plastic stents

  • Experimental
    Self-expandable metalic stent

    Self-expandable metalic stent after sphincterotomy. Stent removal scheduled for 6 months

    Device: Self-expandable metalic stent

Interventions

  • DeviceSelf-expandable metalic stent

    Comparison of self-expandable metalic stent versus multiple plastic stents in post OLT biliary stenosis.

    Also known as: Wallflex, Boston Scientific

  • DeviceMultiple plastic stents

    Comparison of self-expandable metalic stent versus multiple plastic stents in post OLT biliary stenosis.

    Also known as: Boston Scientific, Wilson Cook, Olympus

06

What researchers measure

Primary outcomes

  1. Post OLT biliary stricture resolution after stent removal

    Post OLT biliary stricture resolution will be evaluated during endoscopic stents removal up to 1 year after initial stents placement.

    Time frame: Up to 1 year

Secondary outcomes

  1. Sustained improvement after endoscopic treatment

    Stricture resolution persistent after 1 year

    Time frame: 1 year after biliary stenosis resolution

  2. Occurence and severity of complications related to the endoscopic procedures

    Occurence and severity of complications after therapeutic ERCP will be evaluated and recorded up to 1 month after endoscopic procedures.

    Time frame: Up to 1 month

07

Study locations

1 site
  • Hospital Israelita Albert Einstein
    Sao Paulo, SP 05652900, Brazil
08

References and documents

Publications

  • Mahajan A, Ho H, Sauer B, Phillips MS, Shami VM, Ellen K, Rehan M, Schmitt TM, Kahaleh M. Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video). Gastrointest Endosc. 2009 Aug;70(2):303-9. doi: 10.1016/j.gie.2008.11.029. Epub 2009 Jun 11. PubMed 19523620 ↗
  • Kahaleh M, Behm B, Clarke BW, Brock A, Shami VM, De La Rue SA, Sundaram V, Tokar J, Adams RB, Yeaton P. Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest Endosc. 2008 Mar;67(3):446-54. doi: 10.1016/j.gie.2007.06.057. PubMed 18294506 ↗
  • Traina M, Tarantino I, Barresi L, Volpes R, Gruttadauria S, Petridis I, Gridelli B. Efficacy and safety of fully covered self-expandable metallic stents in biliary complications after liver transplantation: a preliminary study. Liver Transpl. 2009 Nov;15(11):1493-8. doi: 10.1002/lt.21886. PubMed 19877248 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 26, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01148199
Lead sponsor
Hospital Israelita Albert Einstein
Responsible party
FERNANDA PRATA MARTINS (Attending phisician, Hospital Israelita Albert Einstein) — Principal investigator
First posted
Jun 22, 2010
Start date
Aug 2009
Primary completion
Feb 2015
Completion
Feb 2016
Last update
Jun 26, 2018

Study contacts

FERNANDA P MARTINS, MD
principal investigator · Hospital Israelita Albert Einstein
ANGELO P FERRARI, MD
study chair · Hospital Israelita Albert Einstein

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion